반응식
[Cl:1][C:2]1[CH:3]=[C:4]([S:9][C:10]2[N:14]([CH3:15])[C:13]([CH2:16][CH2:17][OH:18])=[N:12][C:11]=2[CH:19]([CH3:21])[CH3:20])[CH:5]=[C:6]([Cl:8])[CH:7]=1.[CH2:22]([O:24][C:25]1(OCC)[CH2:36][CH2:35][CH2:34][CH2:33][CH2:32][CH2:31][CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]1)[CH3:23]>>[Cl:8][C:6]1[CH:5]=[C:4]([S:9][C:10]2[N:14]([CH3:15])[C:13]([CH2:16][CH2:17][O:18][C:25]3([O:24][CH2:22][CH3:23])[CH2:36][CH2:35][CH2:34][CH2:33][CH2:32][CH2:31][CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]3)=[N:12][C:11]=2[CH:19]([CH3:21])[CH3:20])[CH:3]=[C:2]([Cl:1])[CH:7]=1참가 물질
3
실험 절차
The compound 22 (345 mg, 1 mmol) was converted to the acetal with 1,1-diethoxycyclododecane (2.56 g, 00 mmol) in the same manner as the example 20 to give the compound 33 (162 mg, 29%).
출처 및 근거
- ORD 기록
- ord-3ccb28547e3e4c3b8c22cdea72d9ad8f
- 출처 데이터셋
- uspto-grants-2000_04
- 특허 번호
- US06054591
연결된 노트
불러오는 중…